Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Home
<
List for "N04BA03" (37)
–
Sort according to Concentration, Size and Price
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
Levodopa, Decarboxylase Inhibitor and Comt Inhibitor (N04BA03) 37 products
WHO-DDD
DrugBank.ca
IP
CI
Stalevo 50/12.5/200 mg
-
T
30 Tablet(s)
20.15
38.15
10 %
Coated tablets: 3 Active Agents
Orion Pharma AG
B / SL / SO
FB
G
IP
CI
Stalevo 50/12.5/200 mg
-
T
100 Tablet(s)
63.37
84.75
10 %
Coated tablets: 3 Active Agents
Orion Pharma AG
B / SL / SO
FB
G
IP
CI
Stalevo 75/18.75/200 mg
30 Tablet(s)
21.07
39.15
10 %
Coated tablets: 3 Active Agents
Orion Pharma AG
B / SL / SO
FB
G
IP
CI
Stalevo 75/18.75/200 mg
100 Tablet(s)
65.89
87.45
10 %
Coated tablets: 3 Active Agents
Orion Pharma AG
B / SL / SO
FB
G
IP
CI
Stalevo 100/25/200 mg
-
T
30 Tablet(s)
21.99
40.15
10 %
Coated tablets: 3 Active Agents
Orion Pharma AG
B / SL / SO
FB
G
IP
CI
Stalevo 100/25/200 mg
-
T
100 Tablet(s)
68.41
90.20
10 %
Coated tablets: 3 Active Agents
Orion Pharma AG
B / SL / SO
FB
G
IP
CI
Stalevo 125/31.25/200 mg
30 Tablet(s)
22.78
41.00
10 %
Coated tablets: 3 Active Agents
Orion Pharma AG
B / SL / SO
FB
G
IP
CI
Stalevo 125/31.25/200 mg
100 Tablet(s)
70.54
92.50
10 %
Coated tablets: 3 Active Agents
Orion Pharma AG
B / SL / SO
FB
G
IP
CI
Stalevo 150/37.5/200 mg
-
T
30 Tablet(s)
23.56
41.80
10 %
Coated tablets: 3 Active Agents
Orion Pharma AG
B / SL / SO
FB
G
IP
CI
Stalevo 150/37.5/200 mg
-
T
100 Tablet(s)
72.65
94.75
10 %
Coated tablets: 3 Active Agents
Orion Pharma AG
B / SL / SO
FB
G
IP
CI
Stalevo 200/50/200 mg
30 Tablet(s)
25.25
43.65
10 %
Coated tablets: 3 Active Agents
Orion Pharma AG
B / SL / SO
FB
G
IP
CI
Stalevo 200/50/200 mg
100 Tablet(s)
77.15
99.60
10 %
Coated tablets: 3 Active Agents
Orion Pharma AG
B / SL / SO
FB
G
IP
CI
Lecapon-Mepha 50 mg /
12.5 mg / 200 mg
30 Tablet(s)
17.13
35.05
10 %
Coated tablets: 3 Active Agents
Mepha Pharma AG
B / SL / SG
FB
G
IP
CI
Lecapon-Mepha 50 mg /
12.5 mg / 200 mg
100 Tablet(s)
53.88
75.00
10 %
Coated tablets: 3 Active Agents
Mepha Pharma AG
B / SL / SG
FB
G
IP
CI
Lecapon-Mepha 75 mg /
18.75 mg / 200 mg
30 Tablet(s)
17.91
35.90
10 %
Coated tablets: 3 Active Agents
Mepha Pharma AG
B / SL / SG
FB
G
IP
CI
Lecapon-Mepha 75 mg /
18.75 mg / 200 mg
100 Tablet(s)
56.02
77.35
10 %
Coated tablets: 3 Active Agents
Mepha Pharma AG
B / SL / SG
FB
G
IP
CI
Lecapon-Mepha 100 mg / 25 mg / 200 mg
30 Tablet(s)
18.70
36.75
10 %
Coated tablets: 3 Active Agents
Mepha Pharma AG
B / SL / SG
FB
G
IP
CI
Lecapon-Mepha 100 mg / 25 mg / 200 mg
100 Tablet(s)
58.16
79.65
10 %
Coated tablets: 3 Active Agents
Mepha Pharma AG
B / SL / SG
FB
G
IP
CI
Lecapon-Mepha 125 mg /
31.25 mg / 200 mg
30 Tablet(s)
19.36
37.45
10 %
Coated tablets: 3 Active Agents
Mepha Pharma AG
B / SL / SG
FB
G
IP
CI
Lecapon-Mepha 125 mg /
31.25 mg / 200 mg
100 Tablet(s)
59.97
81.65
10 %
Coated tablets: 3 Active Agents
Mepha Pharma AG
B / SL / SG
FB
G
IP
CI
Lecapon-Mepha 150 mg /
37.5 mg / 200 mg
30 Tablet(s)
20.03
38.20
10 %
Coated tablets: 3 Active Agents
Mepha Pharma AG
B / SL / SG
FB
G
IP
CI
Lecapon-Mepha 150 mg /
37.5 mg / 200 mg
100 Tablet(s)
61.76
83.60
10 %
Coated tablets: 3 Active Agents
Mepha Pharma AG
B / SL / SG
FB
G
IP
CI
Lecapon-Mepha 200 mg / 50 mg / 200 mg
30 Tablet(s)
21.47
39.75
10 %
Coated tablets: 3 Active Agents
Mepha Pharma AG
B / SL / SG
FB
G
IP
CI
Lecapon-Mepha 200 mg / 50 mg / 200 mg
100 Tablet(s)
65.58
87.75
10 %
Coated tablets: 3 Active Agents
Mepha Pharma AG
B / SL / SG
FB
G
IP
CI
Lecigon
7 x 47 ml
PR
PR
k.A.
Gel for intestinal application: 3 Active Agents
Spirig HealthCare AG
B
FB
G
IP
CI
Entacapon Plus Sandoz
50/12.5/200 mg
30 Tablet(s)
PR
PR
k.A.
Coated tablets: 3 Active Agents
Sandoz
Pharmaceuticals AG
B
FB
G
IP
CI
Entacapon Plus Sandoz
50/12.5/200 mg
100 Tablet(s)
PR
PR
k.A.
Coated tablets: 3 Active Agents
Sandoz
Pharmaceuticals AG
B
FB
G
IP
CI
Entacapon Plus Sandoz
75/18.75/200 mg
30 Tablet(s)
PR
PR
k.A.
Coated tablets: 3 Active Agents
Sandoz
Pharmaceuticals AG
B
FB
G
IP
CI
Entacapon Plus Sandoz
75/18.75/200 mg
100 Tablet(s)
PR
PR
k.A.
Coated tablets: 3 Active Agents
Sandoz
Pharmaceuticals AG
B
FB
G
IP
CI
Entacapon Plus Sandoz
100/25/200 mg
30 Tablet(s)
PR
PR
k.A.
Coated tablets: 3 Active Agents
Sandoz
Pharmaceuticals AG
B
FB
G
IP
CI
Entacapon Plus Sandoz
100/25/200 mg
100 Tablet(s)
PR
PR
k.A.
Coated tablets: 3 Active Agents
Sandoz
Pharmaceuticals AG
B
FB
G
IP
CI
Entacapon Plus Sandoz
125/31.25/200 mg
30 Tablet(s)
PR
PR
k.A.
Coated tablets: 3 Active Agents
Sandoz
Pharmaceuticals AG
B
FB
G
IP
CI
Entacapon Plus Sandoz
125/31.25/200 mg
100 Tablet(s)
PR
PR
k.A.
Coated tablets: 3 Active Agents
Sandoz
Pharmaceuticals AG
B
FB
G
IP
CI
Entacapon Plus Sandoz
150/37.5/200 mg
30 Tablet(s)
PR
PR
k.A.
Coated tablets: 3 Active Agents
Sandoz
Pharmaceuticals AG
B
FB
G
IP
CI
Entacapon Plus Sandoz
150/37.5/200 mg
100 Tablet(s)
PR
PR
k.A.
Coated tablets: 3 Active Agents
Sandoz
Pharmaceuticals AG
B
FB
G
IP
CI
Entacapon Plus Sandoz
200/50/200 mg
30 Tablet(s)
PR
PR
k.A.
Coated tablets: 3 Active Agents
Sandoz
Pharmaceuticals AG
B
FB
G
IP
CI
Entacapon Plus Sandoz
200/50/200 mg
100 Tablet(s)
PR
PR
k.A.
Coated tablets: 3 Active Agents
Sandoz
Pharmaceuticals AG
B
FB
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2025
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home
